vTv Therapeutics Inc. filed its 10-K on Mar 06, 2023 for the period ending Dec 31, 2022. In this report its auditor, Ernst & Young LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.9 USD | +0.07% | +3.99% | +142.61% |
May. 09 | VTv Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 14 | VTv Therapeutics Inc. Announces Board Changes | CI |
1st Jan change | Capi. | |
---|---|---|
+142.61% | 67.83M | |
+9.42% | 114B | |
+11.84% | 104B | |
-14.15% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.16% | 17.89B | |
+7.99% | 14.28B | |
+36.24% | 12.55B |
- Stock Market
- Equities
- VTVT Stock
- News vTv Therapeutics Inc.
- VTv Therapeutics Inc. Auditor Raises 'Going Concern' Doubt